of prostate cancer that doctors are familiar with or how itmight affect standard treatments.Deshmukh teamed up with collaborators at Icahn School ofMedicine at Mount Sinai and The University of Texas MDAnderson Cancer Center to model the effects of HIV andHIV treatment on prostate cancer.The trio received a $3.4 million grant from the NationalCancer Institute to develop guidance on optimal ways tomanage prostate cancer among people with HIV.GVHD biomarkers2023 Researchby the numbers31150high-impact publications83NCI awards$15.0M166$26.3MBlood cancer patients receiving stem cells from a donorface the possibility of a common side effect – graft-versushost-disease (GVHD), in which the donated cells beginattacking the patient’s own healthy cells. Chronic GVHDranges from mild to severe; unfortunately, it can be quitedebilitating and is a major cause of death for patients.Treatments for chronic GVHD are improving, but it is soprevalent that there is still a strong need to identify patientsat most risk of developing this condition so it can be caughtand treated early, said Sophie Paczesny, M.D., Ph.D.Paczesny led a multicenter team that reported in theJournal of Clinical Investigation that it’s identified threerisk biomarkers that could be measured at 90 days aftertransplantation, long before a doctor would be able tomake a clinical diagnosis of chronic GVHD.Paczesny said the next step would be to create an algorithmwith a cut-off score designating who should be consideredhigh risk and then to move this into a clinical trial providingpreemptive treatment to those who test as high risk.Celebrating 30 Yearspublications(Impact Factor > 10)NCI fundingpeer-reviewed awardspeer-reviewed funding12new memberscbiScott Eblen, Ph.D.cbiLu Han, Ph.D.cbiJudit Jiménez-Sainz, Ph.D.cbiMartin Kang, Ph.D.cbiCasey Langdon, Ph.D.cbiSouvik Seal, Ph.D.cbiBen Strickland, M.D.cPCHazel Breland, Ph.D.cPCKathryn Engelhardt, M.D.cPCJoni Nelson, Ph.D.DcTThai Ho, M.D., Ph.D.DcTKevin Roggin, M.D.11
It seems that your browser's pop-up blocker has prevented us from opening a new window/tab. Please click the button below to open the link manually.